Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response

Epigenomics, Ahead of Print.

Source: Future Medicine: Epigenomics - March 26, 2024 Category: Genetics & Stem Cells Authors: Irene Fischetti Laura Botti Roberta Sulsenti Valeria Cancila Claudia Enriquez Renata Ferri Marco Bregni Filippo Crivelli Claudio Tripodo Mario P. Colombo Elena Jachetti Source Type: research